semaglutide and alzheimer's Preventative tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of disease | Christoffer Clemmensen Semaglutide in early-stage Alzheimer's Disease

& Sahay, G

Microbial drivers of cognitive decline We next sought to use these experimental microbiome perturbations to identify elements of the bacterial microbiota that are involved in the regulation of cognitive decline

These fluctuations cause nighttime awakenings, light sleep, morning headaches, and grogginess

It increases radiance Many of us struggle with a dull or tired-looking complexion after winter

Of the articles reviewed in this report, almost half reported a significant increase in RGC among GLP-1 RA users (Santos et al

Pulls receptors off the cell surface, causes the drug to stop working over time, and may trigger nausea